Transforming TB Detection
at Population Scale

MedInno equips decentralised laboratories, mobile clinics and field teams with molecular diagnostic solutions designed to support timely tuberculosis detection across India.

Partner With Us
OVERVIEW

TB is a Universal Crisis

Despite being curable, tuberculosis remains the world's deadliest infectious killer, spreading fastest where diagnostic access is thinnest and treatment begins too late.

10.6M

New TB Cases

1.3M

Deaths Per Year

3M+

Undiagnosed Cases

THE MEDINNO APPROACH

A scalable workflow designed to reduce the cost of population-wide testing

SCREENING WORKFLOW

Geographic Mapping

We map high-TB-burden districts using regional prevalence data, directing field teams to the villages where transmission risk is greatest.

SCREENING WORKFLOW

Community Mobilization

Local health workers and community volunteers identify presumptive cases through door-to-door outreach and symptom screening camps.

SCREENING WORKFLOW

Sample Collection

Trained technicians collect sputum samples on-site using simple, low-infrastructure protocols suited to rural clinics and mobile vans.

SCREENING WORKFLOW

Rapid Molecular Testing

Samples are processed on portable Real-Time PCR platforms, delivering accurate results within hours instead of days.

SCREENING WORKFLOW

Treatment Linkage & Reporting

Confirmed cases are logged on our digital dashboard and linked directly to local treatment centres for immediate care.

Technology

Screening Technology Beyond Labs

MedInno's molecular platforms are engineered for heat, dust, and unreliable power, so accurate TB testing works in the field as well as in a hospital lab.

Nucleic Acid Extraction

Our low-cost extraction kits isolate M. tuberculosis DNA from sputum without cold storage, refrigerated reagents, or specialized lab technicians.

Targeted Real-Time PCR

Purpose-built primers detect TB and rifampicin-resistance markers in a single run, cutting diagnosis-to-treatment time from weeks to hours.

Field-Ready Infrastructure

Battery-powered instruments and rugged carry cases keep testing operational through power cuts, heat, and long-distance field deployments.

Impact On Systems

Greater Rural Reach

Decentralised testing brings TB diagnosis to sub-district health posts, cutting travel time and turnaround for patients in remote areas.

Impact On Systems

Faster Case Notification

Digital results reach state TB cells the same day, shrinking the gap between diagnosis and official case notification.

Impact On Systems

Reduced Loss to Follow-Up

Same-visit results mean patients start treatment before they disengage from care, a major driver of TB relapse and spread.

FOR LOW-RESOURCE SETTINGS

Designed for gaps in standard diagnostic systems.

Metropolitan labs assume constant electricity, sterile clinical counters, and advanced laboratory engineers. Remote blocks present real structural barriers: spotty power, extreme heat, unpaved terrain, and diagnostic resource shortages.

MedInno systematically optimizes molecular reagents to maintain thermal tolerance, packages workflows inside portable rugged travel cases, and optimizes software for offline-sync data logging.
Collaboration

Mass screening is most effective as a public-health effort.

Government Health Departments Public Health & Multilateral Bodies NGOs & Global Health Foundations CSR & Corporate Partners
icon

Government Health Departments

National and state TB programmes rely on MedInno to extend testing beyond hospital labs into block-level health centres, helping meet case-detection targets under the National TB Elimination Programme without expanding permanent lab infrastructure.

icon

Public Health & Multilateral Bodies

Organisations such as the Global Fund and WHO's End TB partners use MedInno's field data to track case-finding progress and direct funding toward the districts with the largest diagnostic gaps.

icon

NGOs & Global Health Foundations

NGOs running active case-finding drives pair our portable kits with community health workers, reaching migrant labour camps, tea gardens, and informal settlements that hospital-based testing rarely covers.

icon

CSR & Corporate Partners

Corporate CSR programmes fund mobile screening camps for factory workers and surrounding communities, combining compliance with measurable public-health impact in high-burden districts.

Join Us in Strengthening Tuberculosis Detection


MedInno partners with governments, NGOs and healthcare institutions to expand access to molecular tuberculosis testing across decentralised and underserved settings.

Get In Touch